Arnon Toussia Cohen

DiA Imaging Analysis is a leading global provider of FDA-cleared and CE-marked ultrasound AI software that automates how clinicians use and analyze ultrasound images. The companys LVivo product line for cardiac and abdominal automated analysis allows clinicians with varying levels of ultrasound experience to automatically analyze ultrasound images increasing speed, efficiency, and accuracy. Our AI-based cardiac ultrasound analysis software LVivo Seamless™ runs behind-the-scenes, automatically selecting and analyzing the optimal apical views, then generating reproducible and accurate key measurements including Strain, EF and RV size and function on every echo exam. Today, DiA serves thousands of end-users worldwide. DiA was recognized as one of Fast Companys 2022 World Changing Ideas in the Health Category and was recently named as one of CB Insights most innovative digital health startups. Dia was acquired by Philips in 2023

Nucleix is a liquid biopsy company revolutionizing cancer treatment with earlier disease detection at a time when intervention can bring the greatest impact for patients. Leveraging NGS-based and PCR-based technology to identify methylation changes, the Company’s pioneering testing approach uses methylation-based identification for early-stage and recurring cancer detection. The Company’s non-invasive EpiCheck® delivers highly accurate and sensitive results, all while providing a seamless testing option for physicians, patients, and the healthcare system. The Company is building an EpiCheck® franchise, beginning with the Bladder EpiCheck® kit, CE-marked and available in Europe for primary and recurrent bladder cancer and upper tract urinary cancer, and FDA 510(k) cleared for bladder cancer recurrence in the United States. The Company is advancing its Lung EpiCheck® test towards commercialization for high-risk individuals while evaluating additional tests for other high-risk diseases.

DiA Imaging Analysis is a leading global provider of FDA-cleared and CE-marked ultrasound AI software that automates how clinicians use and analyze ultrasound images. The companys LVivo product line for cardiac and abdominal automated analysis allows clinicians with varying levels of ultrasound experience to automatically analyze ultrasound images increasing speed, efficiency, and accuracy. Our AI-based cardiac ultrasound analysis software LVivo Seamless™ runs behind-the-scenes, automatically selecting and analyzing the optimal apical views, then generating reproducible and accurate key measurements including Strain, EF and RV size and function on every echo exam. Today, DiA serves thousands of end-users worldwide. DiA was recognized as one of Fast Companys 2022 World Changing Ideas in the Health Category and was recently named as one of CB Insights most innovative digital health startups. Dia was acquired by Philips in 2023